Moore Capital Management’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$544K Sell
50,000
-150,000
-75% -$1.63M 0.01% 526
2026
Q1
$2.17M Hold
200,000
– – 0.04% 269
2025
Q4
$2.14M Hold
200,000
– – 0.03% 363
2025
Q3
$2.12M Hold
200,000
– – 0.03% 352
2025
Q2
$2.11M Hold
200,000
– – 0.03% 315
2025
Q1
$2.07M Hold
200,000
– – 0.04% 260
2024
Q4
$2.03M Hold
200,000
– – 0.02% 325
2024
Q3
$2.02M Buy
+200,000
New +$2M 0.04% 303

Other funds holding GPAT

Moore Capital Management's GPAT Position: Q2 2026 in Review

Moore Capital Management reduced its GP-Act III Acquisition Corp (GPAT) stake by 75% in Q2 2026, selling an estimated $1.63M and leaving 50,000 shares worth $544K. The position accounts for 0.01% of the portfolio, ranked #526.

Moore Capital Management first reported a position in GPAT in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.17M in Q1 2026. 24 funds tracked by Wall St. Rank hold GPAT as of Q2 2026.

  • Moore Capital Management held 50,000 shares of GP-Act III Acquisition Corp worth $544K as of Q2 2026.
  • Moore Capital Management sold 150,000 GP-Act III Acquisition Corp shares in Q2 2026, an estimated $1.63M.
  • GP-Act III Acquisition Corp made up 0.01% of Moore Capital Management's portfolio in Q2 2026, its #526 holding.
  • Moore Capital Management first reported a position in GP-Act III Acquisition Corp in Q3 2024 and has held it in 8 quarters since.
  • Moore Capital Management's GP-Act III Acquisition Corp position peaked at $2.17M in Q1 2026.
  • 24 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.